Jason Zhao is a member of the firm’s Asia-based M&A team and focuses on private equity transactions and cross-border M&As. He primarily serves private equity funds and corporate clients on a wide range of corporate transactions including buyouts, PIPEs, US going-private, pre-IPO, carve-outs, and growth capital investments, with a particular focus on the Greater China market.

Prior to joining Latham, Mr. Zhao worked at another leading global law firm. He has practiced law in both China and the US.

Mr. Zhao’s recent representative experience includes advising:

  • Trustar Capital, formerly CITIC Capital Partners, as a major member of the buyer consortium on the US$4.76 billion going private of US-listed China Biologic Products Holdings Inc., a developer of plasma-based therapies
  • Aspex as a member of the buyer consortium on the going private of US-listed New Frontier Health Corporation, operator of the premium healthcare services provider United Family Healthcare
  • A buyer consortium led by Mr. Bing Zhang, the chief executive officer and chairman of Glory Star New Media Group Holdings Limited (GSMG), in the proposed going private of GSMG
  • Trustar Capital, formerly CITIC Capital Partners, and its affiliate on the acquisition of Salion Food Condiment Company Limited, a manufacturer of condiments and seasonings with its principal business in China
  • MBK Partners Fund V, L.P. on the US$950 million acquisition of ocean parks located across China from Hong Kong-listed hospitality group Haichang Ocean Park Holdings Ltd.
  • Haier Electronics Group on its proposed acquisition of a controlling stake in Ozner Water International Holding Limited, a China-based water and air purification company listed in Hong Kong
  • CPPIB  in its investment in Hutchison China MediTech Limited, an innovative biopharmaceutical company in China dual-listed on the London Stock Exchange’s AIM market and on the Nasdaq Global Select Market
  • Aspex Management as lead investor in the pipe investment in conjunction with a de-SPAC merger between an Asian sponsored SPAC and a North American-based biotech company
  • Primavera on its:
    • Series C financing of LoveBonito, Singapore's leading fashion online store for women's wear
    • Series B financing of Hex Trust, digital asset custody platform
    • Series B+ financing for a Chinese biomedical company
  • Kuaishou, a technology company that develops content sharing platforms, on its Series F financing
  • Tencent Music Entertainment Group on its minority investment and business cooperation with Wave XR Inc., a US-based virtual concert company that assists artists in live performance avatar creations
  • Jiangxi Copper on its acquisition of three copper mines in Albania*
  • Jiangxi Copper on its acquisition of a tungsten mine in Kazakhstan*
  • Lukoil on its sale of energy assets in Kazakhstan to Sinopec*
  • The general partner of a multi-billion private equity fund on its self-tender offer to restructure the fund for a potential IPO*
  • A number of US-based religious congregations on their civil configuration*

*Matter handled prior to joining Latham

Bar Qualification

  • New York


  • LL.M., College of William & Mary, 2015
  • LL.M., Queen Mary, University of London, 2011

Languages Spoken

  • Chinese (Mandarin)
  • English